Cue Health Appoints Nitin Duggal as Chief Marketing Officer


Experienced leader brings over 15 years of marketing and product development expertise to leading healthcare companies

SAN DIEGO, December 16, 2021 / PRNewswire / – Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a health technology company, today announced that it has appointed Nitin Duggal as the first Director of Marketing, with immediate effect. In his new role, he will be responsible for leading all marketing initiatives at Cue, including partners, directly to consumers, customers, employers and suppliers.

Nitin Duggal

Nitin has over 15 years of leadership experience in high growth technology organizations in Silicon Valley. During his tenure, he developed a proven track record in scaling innovative technology platforms, developing robust product portfolios and leading high performing teams. Nitin joins Cue to help further strengthen the company’s brand, marketing and technology capabilities across its platform and virtual care products.

“On behalf of everyone at Cue, I am delighted to welcome Nitin to Cue. Nitin brings a wealth of experience in developing product marketing strategies and building teams around consumer insight, which, we hope will contribute significantly to our mission to empower people to live their healthiest lives as Cue enters its next chapter of growth, ”said Ayub Khattak, co-founder and CEO of Cue.

“I am honored to be a part of the Cue family and thrilled to be embarking together on a journey that we believe will transform the health experience for consumers. The COVID-19 pandemic has revealed the fragility of our healthcare system and Cue Health is uniquely positioned to offer innovative solutions that are already empowering more and more people to take charge of their health. Together we can make meaningful changes to the healthcare space, ”added Nitin Duggal.

Nitin joins Cue after working at Abbott Diabetes Care, where he held several leadership roles for 10 years. Most recently, he served as Senior Commercial Director within Abbott’s Biowearables group to promote and market detection technology to the non-diabetic population. Nitin also created a digital health group in the United States to redefine the consumer’s journey and explore other reimbursement models. Prior to that he launched a number of Libre® products in the US market as Senior Marketing Director and was Marketing Manager for the launch of FreeStyle® Libre in European markets.

Prior to Abbott, Nitin was a consultant at McKinsey & Co and focused on the healthcare industry. During his time at McKinsey, he led various engagements with payers and medical device companies. Nitin received his MBA from the Tuck School of Business at Dartmouth and holds an undergraduate degree in electronics and electrical communication.

About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company that provides individuals with easy access to health information and puts diagnostic information at the center of care. Cue Health empowers people to manage their health with real-time, actionable, and connected health information, giving individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, no whenever, in a device that fits in the palm of your hand. The COVID-19 test, the first of its kind from Cue Health, was the first molecular diagnostic test cleared by the FDA for home and over-the-counter use without a prescription and without physician supervision. Out United States, Cue Health has received CE Mark in the European Union, Interim Prescription Authorization from Health Canada, Regulatory Approval from india Central Drugs Standard Control Organization and PSAR authorization of that of Singapore Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit

(PRNewsfoto / Cue Health Inc.)

(PRNewsfoto / Cue Health Inc.)



View original content to download multimedia:

SOURCE Cue Santé Inc.


Comments are closed.